AIPT Precision Therapeutics

Axe Compute Explores Strategic Options for its Helomics Business as Company Sharpens AI Compute Focus

Axe Compute Explores Strategic Options for its Helomics Business as Company Sharpens AI Compute Focus

PITTSBURGH, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Axe Compute, Inc. (NASDAQ: AGPU) today announced that it has engaged Cardiff Advisory LLC, a leading investment bank specializing in life sciences and strategic advisory services, to assist the Company in exploring strategic alternatives for its Helomics Business.

The strategic review process will be conducted under the oversight of the Company’s Board of Directors and may include a sale, partnership, licensing arrangement, joint venture, or other transaction involving the Company’s biobank platform and related operations. The review reflects the Company’s continued focus on advancing its AI compute infrastructure strategy while evaluating opportunities to maximize shareholder value from non-core legacy assets.

The biobank platform operates with CLIA-certified laboratory capabilities and includes one of the industry’s most comprehensive collections of oncology research materials, including approximately 150,000 live and frozen tumor samples, 40,000 FFPE tissue blocks, more than 200,000 pathology slides and digital images, and 20 years of historical drug response data spanning over 137 tumor subtypes.

“Axe Compute is focused on executing our compute infrastructure strategy, and we believe this is the appropriate time to evaluate strategic alternatives for our legacy biobank assets,” said Christopher Miglino, Chief Executive Officer of Axe Compute. “This process is a priority for the Company, and we have received preliminary interest from multiple parties and have begun evaluating potential transaction pathways.”

There can be no assurance that the strategic review process will result in any transaction. The Company does not intend to disclose further developments unless and until its Board of Directors approves a specific course of action or determines that additional disclosure is appropriate.

For more information:

David H. Crean

Managing Partner

Cardiff Advisory LLC.

  

About Axe Compute

Axe Compute (NASDAQ: AGPU) plans to make world-class AI compute accessible to all through its access to the Aethir network. By delivering Aethir-provided decentralized global infrastructure, Axe Compute will endeavor to deliver instant access to bare-metal GPUs at scale to innovators and established businesses alike. Axe Compute is where decentralized choice meets enterprise trust.

axecompute.com |

Forward Looking Statements

This press release contains “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. This press release also includes express and implied forward-looking statements regarding the Company’s current expectations, estimates, opinions and beliefs that are not historical facts. Such forward-looking statements may be identified by words such as “believes,” “expects,” “endeavors,” “anticipates,” “intends,” “plans,” “estimates,” “projects,” “should” and “objective” and the negative and variations of such words and similar words. These statements are made on the basis of current knowledge and, by their nature, involve numerous assumptions and uncertainties. Nothing set forth herein should be regarded as a representation, warranty or prediction that we will achieve or are likely to achieve any particular future result. Actual results may differ materially from those indicated in the forward-looking statements because the realization of those results is subject to many risks and uncertainties, including the Company’s ability to successfully execute its digital asset treasury strategy and the implications for shareholders and the Company’s core business, fluctuations in the market price of ATH and other digital assets, the impact of the evolving regulatory environment on the Company’s business, the ability of the Aethir ecosystem to perform in a manner consistent with projections, and general market, economic, and business conditions, as well as other factors. Forward-looking statements contained in this press release are made as of the date of this press release, and the Company undertakes no duty to update such information except as required under applicable law.

Investor Relations Contact:



EN
24/02/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Precision Therapeutics

 PRESS RELEASE

Axe Compute Explores Strategic Options for its Helomics Business as Co...

Axe Compute Explores Strategic Options for its Helomics Business as Company Sharpens AI Compute Focus PITTSBURGH, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Axe Compute, Inc. (NASDAQ: AGPU) today announced that it has engaged Cardiff Advisory LLC, a leading investment bank specializing in life sciences and strategic advisory services, to assist the Company in exploring strategic alternatives for its Helomics Business. The strategic review process will be conducted under the oversight of the Company’s Board of Directors and may include a sale, partnership, licensing arrangement, joint venture, or ...

 PRESS RELEASE

Axe Compute Appoints Christopher Miglino as Chief Executive Officer, U...

Axe Compute Appoints Christopher Miglino as Chief Executive Officer, Ushering in a New Era of Decentralized Compute PITTSBURGH, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Axe Compute (or the “Company”) (Nasdaq: AGPU) today announced the appointment of Christopher Miglino as Chief Executive Officer, marking a pivotal development in the company’s commitment to decentralized compute and digital infrastructure, operating at the intersection of blockchain, AI, and capital markets. Mr. Miglino transitions into the CEO role following his involvement in the structuring of Axe Compute’s digital asset trea...

 PRESS RELEASE

Predictive Oncology Becomes Axe Compute, Expanding Into High-Performan...

Predictive Oncology Becomes Axe Compute, Expanding Into High-Performance AI Infrastructure NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Axe Compute Inc. (NASDAQ: AGPU) (the “Company” or “Axe Compute”) today announced that it has changed its name to Inc., with its common stock to begin trading on Nasdaq under the ticker symbol AGPU on December 12, 2025. Axe Compute will continue to operate its AI-driven drug discovery business and plans to expand its business into high-performance enterprise AI infrastructure, addressing rising global demand for predictable, scalable compute capacity acros...

 PRESS RELEASE

Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockhold...

Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement PITTSBURGH, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir network, today announced that on December 1, 2025, the Company received a notification letter from Nasdaq notifying the Company that it regained compliance with Nasdaq's minimum stockholders' equity requirement set forth in Nasdaq Listing Rule 5550(b)(1), w...

 PRESS RELEASE

Predictive Oncology Reports Third Quarter 2025 Financial Results and P...

Predictive Oncology Reports Third Quarter 2025 Financial Results and Provides Update on Digital Asset Strategy Company to host investor conference call and webcast on Monday, November 17th, at 9:00am EST PITTSBURGH, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI), an AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir network, today reported financial and operating results for the quarter ended September 30, 2025, and provided a corporate update. Q3 2025 and Recen...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch